CD16+ Macrophages: An Emerging Biomarker for Combined CTLA-4 and PD-1 Blockade

被引：0

作者：

Smithy, James W. ^{[1
]}

Luke, Jason J. ^{[2
,3
,4
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA

[2] UPMC Hillman Canc Ctr, Pittsburgh, PA USA

[3] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA

[4] UPMC Hillman Canc Ctr, Immunotherapy & Drug Dev Ctr, Pittsburgh, PA 15232 USA

来源：

CLINICAL CANCER RESEARCH | 2023年 / 29卷 / 13期

关键词：

IPILIMUMAB; THERAPY; NIVOLUMAB; MELANOMA;

D O I：

10.1158/1078-0432.CCR-23-0490

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In a retrospective analysis of patients with unresectable melanoma, higher pretreatment tissue densities of CD16(+) macrophages were associated with clinical benefit from combined CTLA-4 and PD-1 blockade. With further validation, this biomarker could serve as a tool in selecting between immune checkpoint inhibitor regimens.

引用

页码：2345 / 2347

页数：3

共 20 条

[1] IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade [J].

Ayers, Mark ;

Lunceford, Jared ;

Nebozhyn, Michael ;

Murphy, Erin ;

Loboda, Andrey ;

Kaufman, David R. ;

Albright, Andrew ;

Cheng, Jonathan D. ;

Kang, S. Peter ;

Shankaran, Veena ;

Piha-Paul, Sarina A. ;

Yearley, Jennifer ;

Seiwert, Tanguy Y. ;

Ribas, Antoni ;

McClanahan, Terrill K. .

JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (08) :2930-2940

[2] Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy [J].

Cristescu, Razvan ;

Mogg, Robin ;

Ayers, Mark ;

Albright, Andrew ;

Murphy, Erin ;

Yearley, Jennifer ;

Sher, Xinwei ;

Liu, Xiao Qiao ;

Lu, Hongchao ;

Nebozhyn, Michael ;

Zhang, Chunsheng ;

Lunceford, Jared ;

Joe, Andrew ;

Cheng, Jonathan ;

Webber, Andrea L. ;

Ibrahim, Nageatte ;

Plimack, Elizabeth R. ;

Ott, Patrick A. ;

Seiwert, Tanguy ;

Ribas, Antoni ;

McClanahan, Terrill K. ;

Tomassini, Joanne E. ;

Loboda, Andrey ;

Kaufman, David .

SCIENCE, 2018, 362 (6411) :197-+

[3] Anti-PD-1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases [J].

Dhupkar, Pooja ;

Gordon, Nancy ;

Stewart, John ;

Kleinerman, Eugenie S. .

CANCER MEDICINE, 2018, 7 (06) :2654-2664

[4] Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression [J].

Etzerodt, Anders ;

TsaLkitzi, Kyriaki ;

Maniecki, Maciej ;

Damsky, William ;

Delfini, Marcello ;

Baudoin, ELodie ;

Moulin, Morgane ;

Bosenberg, Marcus ;

Graversen, Jonas Heilskov ;

Auphan-Anezin, Nathalie ;

Moestrup, Soren Kragh ;

Lawrence, Toby .

JOURNAL OF EXPERIMENTAL MEDICINE, 2019, 216 (10) :2394-2411

[5] Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma [J].

Larkin, J. ;

Chiarion-Sileni, V. ;

Gonzalez, R. ;

Grob, J-J ;

Rutkowski, P. ;

Lao, C. D. ;

Cowey, C. L. ;

Schadendorf, D. ;

Wagstaff, J. ;

Dummer, R. ;

Ferrucci, P. F. ;

Smylie, M. ;

Hogg, D. ;

Hill, A. ;

Marquez-Rodas, I. ;

Haanen, J. ;

Guidoboni, M. ;

Maio, M. ;

Schoffski, P. ;

Carlino, M. S. ;

Lebbe, C. ;

McArthur, G. ;

Ascierto, P. A. ;

Daniels, G. A. ;

Long, G. V. ;

Bastholt, L. ;

Rizzo, J. I. ;

Balogh, A. ;

Moshyk, A. ;

Hodi, F. S. ;

Wolchok, J. D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (16) :1535-1546

[6] Intratumoral CD16± Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy [J].

Lee, Hansol ;

Ferguson, Angela L. ;

Quek, Camelia ;

Vergara, Ismael A. ;

daSilva, Ines Pires ;

Allen, Ruth ;

Gide, Tuba Nur ;

Conway, Jordan W. ;

Koufariotis, Lambros T. ;

Hayward, Nicholas K. ;

Waddell, Nicola ;

Carlino, Matteo S. ;

Menzies, Alexander M. ;

Saw, Robyn P. M. ;

Shklovskaya, Elena ;

Rizos, Helen ;

Lo, Serigne ;

Scolyer, Richard A. ;

V. Long, Georgina ;

Palendira, Umaimaintha ;

Wilmott, James S. .

CLINICAL CANCER RESEARCH, 2023, 29 (13) :2513-2524

[7] Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition [J].

Litchfield, Kevin ;

Reading, James L. ;

Puttick, Clare ;

Thakkar, Krupa ;

Abbosh, Chris ;

Bentham, Robert ;

Watkins, Thomas B. K. ;

Rosenthal, Rachel ;

Biswas, Dhruva ;

Rowan, Andrew ;

Lim, Emilia ;

Al Bakir, Maise ;

Turati, Virginia ;

Guerra-Assuncao, Jose Afonso ;

Conde, Lucia ;

Furness, Andrew J. S. ;

Saini, Sunil Kumar ;

Hadrup, Sine R. ;

Herrero, Javier ;

Lee, Se-Hoon ;

Van Loo, Peter ;

Enver, Tariq ;

Larkin, James ;

Hellmann, Matthew D. ;

Turajlic, Samra ;

Quezada, Sergio A. ;

McGranahan, Nicholas ;

Swanton, Charles .

CELL, 2021, 184 (03) :596-+

[8] T cell-induced CSF1 promotes melanoma resistance to PD1 blockade [J].

Neubert, Natalie J. ;

Schmittnaegel, Martina ;

Bordry, Natacha ;

Nassiri, Sina ;

Wald, Noemie ;

Martignier, Christophe ;

Tille, Laure ;

Homicsko, Krisztian ;

Damsky, William ;

Hajjami, Helene Maby-El ;

Klaman, Irina ;

Danenberg, Esther ;

Ioannidou, Kalliopi ;

Kandalaft, Lana ;

Coukos, George ;

Hoves, Sabine ;

Ries, Carola H. ;

Marraco, Silvia A. Fuertes ;

Foukas, Periklis G. ;

De Palma, Michele ;

Speiser, Daniel E. .

SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (436)

[9]

Pittet MJ, 2022, NAT REV CLIN ONCOL, V19, P402, DOI 10.1038/s41571-022-00620-6

[10] Pembrolizumab versus Ipilimumab in Advanced Melanoma [J].

Robert, Caroline ;

Schachter, Jacob ;

Long, Georgina V. ;

Arance, Ana ;

Grob, Jean Jacques ;

Mortier, Laurent ;

Daud, Adil ;

Carlino, Matteo S. ;

McNeil, Catriona ;

Lotem, Michal ;

Larkin, James ;

Lorigan, Paul ;

Neyns, Bart ;

Blank, Christian U. ;

Hamid, Omid ;

Mateus, Christine ;

Shapira-Frommer, Ronnie ;

Kosh, Michele ;

Zhou, Honghong ;

Ibrahim, Nageatte ;

Ebbinghaus, Scot ;

Ribas, Antoni .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (26) :2521-2532

← 1 2 →